T. Palmer

Changes in the prevalence of human papillomavirus following a national bivalent human papillomavirus vaccination programme in Scotland: a 7-year cross-sectional study.

H. Cubie, C. Moore, M. Cruickshank, 2017, The Lancet. Infectious diseases.

HPV immunisation and cervical screening—confirmation of changed performance of cytology as a screening test in immunised women: a retrospective population-based cohort study

S. Cotton, M. Cruickshank, C. Robertson, 2016, British Journal of Cancer.

Changes in HPV prevalence following a national bivalent HPV vaccination programme in Scotland: a 7-year cross-sectional study

H. Cubie, C. Moore, M. Cruickshank, 2017 .

Increased risk of HPV‐associated genital cancers in men and women as a consequence of pre‐invasive disease

M. Cruickshank, Alistair R W Williams, K. Cuschieri, 2019, International journal of cancer.

Use of HPV testing for cervical screening in vaccinated women—Insights from the SHEVa (Scottish HPV Prevalence in Vaccinated Women) study

H. Cubie, K. Cuschieri, K. Kavanagh, 2016, International journal of cancer.

HPV immunisation and increased uptake of cervical screening in Scottish women; observational study of routinely collected national data

M. Cruickshank, C. Robertson, K. Cuschieri, 2016, British Journal of Cancer.

Prevalence of cervical disease at age 20 after immunisation with bivalent HPV vaccine at age 12-13 in Scotland: retrospective population study

M. Cruickshank, C. Robertson, K. Cuschieri, 2019, BMJ.

Defining Optimal Triage Strategies for hrHPV Screen–Positive Women—An Evaluation of HPV 16/18 Genotyping, Cytology, and p16/Ki-67 Cytoimmunochemistry

H. Currie, M. Arbyn, K. Cuschieri, 2017, Cancer Epidemiology, Biomarkers & Prevention.

Reduction of low- and high-grade cervical abnormalities associated with high uptake of the HPV bivalent vaccine in Scotland

H. Cubie, M. Cruickshank, C. Robertson, 2014, British Journal of Cancer.

Clinical performance of triage strategies for Hr-HPV positive women; a longitudinal evaluation of cytology, p16/Ki-67 Dual Stain cytology, and HPV16/18 genotyping.

H. Currie, M. Arbyn, K. Cuschieri, 2022, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Reduction of low- and high-grade cervical abnormalities associated with high of the HPV vaccine in

H. Cubie, K. Kavanagh, K. Pollock, 2018 .

Changes in the prevalence of human papillomavirus following a national bivalent human papillomavirus vaccination programme in Scotland: a 7-year cross-sectional study.

H. Cubie, C. Moore, M. Cruickshank, 2017, The Lancet. Infectious diseases.

Increased risk of HPV-associated genital cancers in men and women as a consequence of 1 pre-invasive disease 2

K. Cuschieri, K. Kavanagh, T. Palmer, 2018 .

The changing nature of HPV associated with high grade cervical lesions in vaccinated populations, a retrospective study of over 1700 cases in Scotland

K. Cuschieri, T. Palmer, R. Cameron, 2023, British Journal of Cancer.

Prevalence of cervical disease at age 20 after immunisation with bivalent HPV vaccine at age 12-13 in Scotland: retrospective population study

K. Cuschieri, T. Palmer, K. Pollock, 2019, BMJ.